From Myths to Facts: Understanding Clinical Trials in MDS
This episode of the Health Tree Podcast for MDS focuses on demystifying clinical trials, particularly for blood cancers like MDS and AML. Host Mary Arnett and guest Logan Murray discuss the importance of clinical trials in advancing treatment options and dispelling common myths, such as the misconception that trials are only for patients with no other options. They emphasize patient safety, informed consent, and the various phases of trials, highlighting that trials are available at different stages of a patient's treatment journey. The episode also addresses logistical concerns, such as travel and costs, and reassures patients about their control and decision-making power throughout the trial process.
Mary introduces the agenda of the event and our featured speaker Logan Murray
Logan discusses the importance of clinical trials in advancing treatment and answers your questions
Mary Arnett
Mary joined HealthTree in 2022 as a part of HealthTree's team to help expand into all blood cancers. She now works as HealthTree's Volunteer & Community Outreach Manager, helping to engage and involve community members in HealthTree's mission. When she isn't working, she loves being the fun aunt to her 13 nieces and nephews, attending concerts, experimenting with new recipes in the kitchen, and traveling to explore new cities.
Logan Murray, PA-C
Logan Murray, PA-C, attended The University of Florida for his Bachelor’s degree, Master’s degree in Physician Assistant Studies and graduate work and clinical training as a Physician Assistant. He subsequently moved to Tampa, FL, gaining experience treating a variety of diseases, primarily Acute Leukemias, lymphomas and multiple myeloma. Logan thoroughly appreciates the complexity of hematologic malignancies and the care that patients require.